Cumberland Pharmaceuticals (CPIX) Total Debt (2016 - 2025)
Historic Total Debt for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Q3 2025 value amounting to $5.2 million.
- Cumberland Pharmaceuticals' Total Debt fell 6743.19% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 6743.19%. This contributed to the annual value of $15.3 million for FY2024, which is 1949.31% up from last year.
- According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Total Debt is $5.2 million, which was down 6743.19% from $5.2 million recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Total Debt registered a high of $20.0 million during Q1 2022, and its lowest value of $5.2 million during Q1 2025.
- For the 5-year period, Cumberland Pharmaceuticals' Total Debt averaged around $14.0 million, with its median value being $15.0 million (2021).
- Its Total Debt has fluctuated over the past 5 years, first skyrocketed by 3571.43% in 2022, then tumbled by 6743.19% in 2025.
- Cumberland Pharmaceuticals' Total Debt (Quarter) stood at $15.0 million in 2021, then grew by 8.0% to $16.2 million in 2022, then dropped by 21.09% to $12.8 million in 2023, then rose by 19.49% to $15.3 million in 2024, then crashed by 65.69% to $5.2 million in 2025.
- Its last three reported values are $5.2 million in Q3 2025, $5.2 million for Q2 2025, and $5.2 million during Q1 2025.